Velarion Records
Free. Unsubscribe any time.

Cadrenal Therapeutics, Inc. (CVKD)

Cadrenal Therapeutics, Inc. filed 19 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 2 reporting owners, covering 37 transactions and 124,277 shares. None carries the SEC's AFF10B5ONE flag; all 19 name a plan in a footnote. No results print is on file in this window, so no interval is measured.

What stands out

Trades in Cadrenal Therapeutics, Inc. 37

Adoption dates in Cadrenal Therapeutics, Inc. 3

Results prints in Cadrenal Therapeutics, Inc. 0

Trades before a print in Cadrenal Therapeutics, Inc. 0

Interval to Cadrenal Therapeutics, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Cadrenal Therapeutics, Inc. states

Filing text: “10b5-1 trading arrangement adopted by the Reporting Person on May 9, 2025”

Sources: SEC EDGAR full-text search and the SEC submissions API.